Key result
Cardiac resynchronization therapy significantly increased pulse wave velocity (from 10.0 to 10.4 m/sec), systolic blood pressure, and cardiac output in patients with heart failure with reduced ejection fraction.
Why the study?
To investigate the effects of CRT on noninvasively evaluated hemodynamic and arterial stiffness parameters in HFrEF, and determine their correlation with clinical response.
Does cardiac resynchronization therapy improve hemodynamic and arterial stiffness parameters in patients with HFrEF?
Observational (n=46)
Single-blind
No
Does cardiac resynchronization therapy improve hemodynamic and arterial stiffness parameters in patients with HFrEF?
Cardiac resynchronization therapy significantly increases systolic blood pressure, cardiac output, and pulse wave velocity, with these modest increases being associated with positive clinical response in HFrEF patients.
Introduction Cardiac resynchronization therapy (CRT) is a device‐based method of treatment which decreases morbidity and mortality in heart failure with reduced ejection fraction (HFrEF). This study was aimed to investigate the effects of CRT on hemodynamic and arterial stiffness parameters evaluated by noninvasive method, and determine whether there is a correlation between the changes after CRT in these parameters and the clinical response to CRT or not. Methods The study included 46 patients with HFrEF who were planned to undergo CRT implantation. Before the CRT implantation, clinical and demographic data were recorded from all patients. Hemodynamic and arterial stiffness parameters were measured oscillometrically by an arteriograph before CRT implantation. The patients were re‐evaluated minimum three months after CRT; the above‐mentioned parameters were measured again and compared to the pre‐CRT period. Results Compared to the period before CRT, mean systolic blood pressure (SBP) (116.8 ± 19.1 mm Hg vs 127.7 ± 20.9 mm Hg, P = .005), central SBP (cSBP) (106.2 ± 17.3 mm Hg vs 116.8 ± 18.7 mm Hg, P = .015), cardiac output (CO) (4.6 ± 0.8 lt/min vs 5.1 ± 0.8 lt/min, P = .002), stroke volume (65.6 ± 16.3 mL vs 72.0 ± 14.9 mL), and pulse wave velocity (PWV) (10 ± 1.6 m/sec vs 10.4 ± 1.8 m/sec, P = .004) increased significantly in post‐CRT period. In addition, the same parameters were significantly increased post‐CRT period in patients with clinical response. However, there was not any similar increase in nonresponder patients. Conclusion This study demonstrated that SBP, CO, and PWV increased significantly after CRT. The modest increases in these parameters were observed to be associated with positive clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Çoksevim et al. (2020) conducted an observational in Heart failure with reduced ejection fraction (HFrEF) (n=46). Cardiac resynchronization therapy vs. Pre-CRT baseline was evaluated on Pulse wave velocity (PWV) (p=0.004). Cardiac resynchronization therapy significantly increased pulse wave velocity (from 10.0 to 10.4 m/sec), systolic blood pressure, and cardiac output in patients with heart failure with reduced ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: